News
The U.S. Food and Drug Administration has approved a prefilled syringe version of Netherlands-based Argenx SE's blockbuster ...
The sudden resignation of Peter Marks, M.D., Ph.D., from the FDA branch that regulates biological products for humans ...
Key to 400-employee Denali's submission is the FDA allowing measurement of a type of GAG, called heparan sulfate, in ...
Traws Pharma, Inc. ( NASDAQ: TRAW) Virtual Investor Event March 31, 2025 10:00 AM ET Werner Cautreels – Chief Executive Officer Robert Redfield – Chief Medical Officer David Pauza – Chief Science ...
It is also one of the 10 best healthcare stocks for long-term investment. For the full year of 2024, United Therapeutics (NASDAQ:UTHR) reported record revenues of $2.88 billion, reflecting 24% ...
In this article, we are going to take a look at where United Therapeutics Corporation (NASDAQ ... It is also one of the 10 best healthcare stocks for long-term investment.
There are definitely things to like about United Therapeutics. With the recent decline, the stock trades at 10.2× forward price-to-earnings (or $308.27 per share). Is now the right time to buy?
If you followed our company for the last several years, you'll remember that since 2018, 3D Systems has been in a terrific partnership with United Therapeutics ... With 10% of the $50 million ...
The biotechnology company reported $6.19 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $6.10 by $0.09. United Therapeutics had a return on equity of 19.22% ...
BUFFALO, N.Y. (WIVB) — A dozen people were displaced by a fire on Monday morning at a large home with multiple residences on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results